GlaxoSmithKline PLC operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.

Block Listing Application

Headline results from phase III FIRST trial

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

GlaxoSmithKline PLC (GSK LN)

Block Listing Application

Headline results from phase III FIRST trial

Jemperli receives US FDA breakthrough designation

EMA grants PRIME Designation for GSK’227

Jemperli receives positive CHMP opinion

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)